+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Predisposition Biomarker"

U.S. Solid Tumor Testing Market: Focus on Technology, Cancer Type, Type of Biomarker, By Application, by End User, and Region - Analysis and Forecast, 2022-2032 - Product Thumbnail Image

U.S. Solid Tumor Testing Market: Focus on Technology, Cancer Type, Type of Biomarker, By Application, by End User, and Region - Analysis and Forecast, 2022-2032

  • Report
  • June 2022
  • 283 Pages
  • United States
From
Predisposition Biomarkers: Technologies and Global Markets - Product Thumbnail Image

Predisposition Biomarkers: Technologies and Global Markets

  • Report
  • October 2019
  • 72 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Predisposition Biomarker market is a subset of the larger Biomarker market. Predisposition Biomarkers are used to identify individuals who are at risk of developing a particular disease or condition. These biomarkers are typically genetic in nature, and can be used to predict the likelihood of a person developing a certain disease or condition. Predisposition Biomarkers are used in a variety of medical applications, including personalized medicine, drug development, and disease prevention. The Predisposition Biomarker market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Illumina, Thermo Fisher Scientific, Qiagen, and Roche. Other companies in the market include Agilent Technologies, Bio-Rad Laboratories, and PerkinElmer. Show Less Read more